Article: ADDITION OF BUDESONIDE TO FORMOTEROL HELPS PATIENTS WITH COPD.

(Full text of a statement. Contact details below.)

BIRMINGHAM, June 28 /PRNewswire-AsiaNet/ - For non-US journalists only

For severe COPD patients treated with budesonide added to either formoterol (Symbicort, AstraZeneca) and/or a short acting bronchodilator, there is a reduced risk of mortality compared to patients treated with only formoterol and/or terbutaline

Important new data from the analysis of combined data from the two pivotal Symbicort(R) studies, announced today at the 5th International Multidisciplinary Conference on Chronic Obstructive Pulmonary Disease (COPD5), reveals that budesonide added to formoterol (Symbicort(R)) and/or ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!